Peapod Lane Capital LLC acquired a new position in shares of Alto Ingredients, Inc. (NASDAQ:ALTO - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 939,097 shares of the company's stock, valued at approximately $1,465,000. Alto Ingredients comprises about 1.5% of Peapod Lane Capital LLC's portfolio, making the stock its 29th biggest holding. Peapod Lane Capital LLC owned about 1.23% of Alto Ingredients as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Empowered Funds LLC increased its position in shares of Alto Ingredients by 4.9% during the fourth quarter. Empowered Funds LLC now owns 253,926 shares of the company's stock worth $396,000 after acquiring an additional 11,949 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in Alto Ingredients by 5.4% during the third quarter. The Manufacturers Life Insurance Company now owns 370,852 shares of the company's stock valued at $597,000 after purchasing an additional 19,104 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of Alto Ingredients by 137.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 58,788 shares of the company's stock valued at $95,000 after buying an additional 34,061 shares during the last quarter. Barclays PLC grew its position in shares of Alto Ingredients by 123.9% in the 3rd quarter. Barclays PLC now owns 76,703 shares of the company's stock valued at $123,000 after acquiring an additional 42,450 shares during the period. Finally, Virtu Financial LLC bought a new position in Alto Ingredients during the third quarter worth about $139,000. Institutional investors and hedge funds own 42.44% of the company's stock.
Alto Ingredients Stock Performance
ALTO traded up $0.07 during trading hours on Monday, reaching $1.58. The company's stock had a trading volume of 791,022 shares, compared to its average volume of 561,534. The firm has a market cap of $121.11 million, a PE ratio of -3.04 and a beta of 1.86. The company's 50-day moving average is $1.61 and its 200-day moving average is $1.56. Alto Ingredients, Inc. has a 52 week low of $1.18 and a 52 week high of $2.40. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.15 and a current ratio of 3.22.
Alto Ingredients Profile
(
Free Report)
Alto Ingredients, Inc produces, distributes, and markets specialty alcohols, renewable fuel, and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Campus Production, and Western Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages and vinegar, as well as corn germ used in corn oils in the food and beverage markets; alcohols and other products for paint applications and fertilizers in the industrial and agriculture markets; and essential ingredients include dried yeast, corn protein meal, corn protein feed, distiller's grains, and liquid feed for commercial animal feed and pet food applications, as well as yeast for human consumption.
Read More

Before you consider Alto Ingredients, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alto Ingredients wasn't on the list.
While Alto Ingredients currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.